Cardiovascular impacts of targeted cancer therapies: the case of BTK (Bruton’s Tyrosine Kinase) inhibitors

Matthew performed his undergraduate studies in biochemistry at the State University of New York College at Geneseo prior to beginning his graduate studies at Yale University in the Department of Cellular and Molecular Physiology. Matthew’s graduate research focused on ion channel modulation by kinases and mechanisms by which dysregulation of these signaling pathways result in pediatric epilepsy. After completion of his PhD, Matthew attended Columbia University’s College of Physicians and Surgeons where he earned his MD as a member of the first class of students in a 3 year PhD to MD/PhD track. After graduation, he began his post-graduate medical training at Vanderbilt University in Internal Medicine as a member of the Harrison Society, Vanderbilt’s Physician Scientist Training Program. Matthew continued his training as a fellow in Cardiology at Vanderbilt and is currently a Fellow in Cardio-Oncology.